1. Home
  2. SAVA vs ZVIA Comparison

SAVA vs ZVIA Comparison

Compare SAVA & ZVIA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Cassava Sciences Inc.

SAVA

Cassava Sciences Inc.

HOLD

Current Price

$2.03

Market Cap

96.1M

Sector

Health Care

ML Signal

HOLD

Logo Zevia PBC

ZVIA

Zevia PBC

HOLD

Current Price

$1.39

Market Cap

96.4M

ML Signal

HOLD

Company Overview

Basic Information
Metric
SAVA
ZVIA
Founded
1998
2007
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Beverages (Production/Distribution)
Sector
Health Care
Consumer Staples
Exchange
Nasdaq
Nasdaq
Market Cap
96.1M
96.4M
IPO Year
N/A
2021

Fundamental Metrics

Financial Performance
Metric
SAVA
ZVIA
Price
$2.03
$1.39
Analyst Decision
Buy
Buy
Analyst Count
2
4
Target Price
$5.00
$4.93
AVG Volume (30 Days)
620.4K
635.1K
Earning Date
01-01-0001
05-25-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
55.88
EPS
N/A
N/A
Revenue
N/A
$161,259,000.00
Revenue This Year
N/A
$8.33
Revenue Next Year
N/A
$6.84
P/E Ratio
N/A
N/A
Revenue Growth
N/A
4.01
52 Week Low
$1.15
$1.11
52 Week High
$4.98
$3.66

Technical Indicators

Market Signals
Indicator
SAVA
ZVIA
Relative Strength Index (RSI) 43.01 33.69
Support Level $2.01 $1.11
Resistance Level $2.29 $2.76
Average True Range (ATR) 0.14 0.10
MACD -0.01 0.00
Stochastic Oscillator 13.21 44.92

Price Performance

Historical Comparison
SAVA
ZVIA

About SAVA Cassava Sciences Inc.

Cassava Sciences Inc is a clinical-stage biotechnology company engaged in developing a scientific approach for the treatment and detection of Alzheimer's disease. Its therapeutic product candidate is called simufilam, and it is a novel treatment for Alzheimer's disease; and investigational diagnostic product candidate is called SavaDx and it is a novel way to detect the presence of Alzheimer's disease from a small sample of blood, possibly years before the overt appearance of clinical symptoms. It is currently conducting two randomized placebo-controlled Phase 3 clinical trials of oral simufilam in patients with Alzheimer's disease dementia. It has one business segment: the development of novel drugs and diagnostics.

About ZVIA Zevia PBC

Zevia PBC is a beverage company disrupting the liquid refreshment beverage industry through refreshing, zero-calorie, zero-sugar, naturally sweetened beverages that are all Non-GMO Project Verified. It offers a platform of products that include a variety of flavors across Soda, Energy Drinks, Organic Tea, Mixers, Kidz drinks, and Sparkling Water. Its products are distributed across the U.S. and Canada through a network of retailers in the food, drug, mass, natural, and e-commerce channels. The company derives a majority of its revenue from the United States.

Share on Social Networks: